D64.81
D64.81: Anemia due to antineoplastic chemotherapy
Billable / specific codeICD-10-CM
D64.81 is a billable, specific ICD-10-CM code for anemia due to antineoplastic chemotherapy. It is valid for submission on a claim.
Check D64.81 with the rest of the claim: free scrubberExcludes2: not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Antineoplastic chemotherapy induced anemia
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
D64.81 is named in 7 Medicare coverage policies: 7 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A56464Billing and Coding: Flow Cytometry
- A56795Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
- A58710Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- A58720Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Alphabetic index entries that lead here
- Anemia›due to›antineoplastic chemotherapy
- Anemia›due to›chemotherapy, antineoplastic
The condition this code belongs to
Code history
Unchanged in every release from FY2024 to FY2027.